Desktop Site |
16 Apr 24 | 14:57 | Open
Equity SME Eq Drv Currency Commodity Corporates
Get Quote  
Notices |
 
S&P BSE SENSEX 72,814.71 -585.07 -0.80 %
Corporate Announcement
  • Security Code532296
    CompanyGLENMARK PHARMACEUTICALS LTD.
    Exchange Received Time23/03/2021 09:01:15
    Exchange Disseminated Time23/03/2021 09:01:20
    Time Taken00:00:05
     
     
     Announcement under Regulation 30 (LODR)-Press Release / Media Release | 3/23/2021 9:01:16 AM 
     Glenmark Pharmaceuticals receives ANDA approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg: Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(24) 16 Apr 24|14:57 (IST)